TY - JOUR
T1 - Mechanistic diversity of Bacteroides fragilis toxins and neutralization with single domain antibody
AU - Guo, Yucheng
AU - Ouyang, Zhenlin
AU - He, Wenbo
AU - Qin, Qian
AU - Zhang, Jiaxin
AU - Yu, Ting
AU - Jiao, Min
AU - Hwang, Peter M.
AU - Zheng, Fang
AU - Muyldermans, Serge
AU - Wen, Yurong
N1 - Publisher Copyright:
© 2025 The Author(s)
PY - 2026/1/15
Y1 - 2026/1/15
N2 - Enterotoxigenic Bacteroides fragilis (ETBF) promotes colonic inflammation by secreting metalloenzyme toxins (BFTs). Understanding BFT mechanisms and developing neutralization strategies is critical. Here, we have solved the structures of BFT-1 and BFT-2, revealing that residue 357 in the active site of the catalytic domain explains the diversity of function observed in BFT subtypes. We demonstrate that BFTs can directly cleave human epithelial-cadherin at extracellular domain 4, with BFT-2 possessing the highest activity. Using an alpaca antibody library, we identified a single-domain antibody, Nb2.43, targeting the BFTs. Nb2.43 can neutralize all three subtypes of BFT by directly binding the metalloenzyme catalytic zinc ion with its CDR3 antigen-binding loop. Furthermore, Nb2.43 blocks cleavage of E-cadherin by BFT and prevents the damage caused by ETBF in vitro and in a mouse colitis model. This work provides structural insights into BFT diversity and delivers a therapeutic nanobody against ETBF-mediated inflammation.
AB - Enterotoxigenic Bacteroides fragilis (ETBF) promotes colonic inflammation by secreting metalloenzyme toxins (BFTs). Understanding BFT mechanisms and developing neutralization strategies is critical. Here, we have solved the structures of BFT-1 and BFT-2, revealing that residue 357 in the active site of the catalytic domain explains the diversity of function observed in BFT subtypes. We demonstrate that BFTs can directly cleave human epithelial-cadherin at extracellular domain 4, with BFT-2 possessing the highest activity. Using an alpaca antibody library, we identified a single-domain antibody, Nb2.43, targeting the BFTs. Nb2.43 can neutralize all three subtypes of BFT by directly binding the metalloenzyme catalytic zinc ion with its CDR3 antigen-binding loop. Furthermore, Nb2.43 blocks cleavage of E-cadherin by BFT and prevents the damage caused by ETBF in vitro and in a mouse colitis model. This work provides structural insights into BFT diversity and delivers a therapeutic nanobody against ETBF-mediated inflammation.
KW - Bacteroides fragilis toxin
KW - E-cadherin
KW - enterotoxigenic Bacteroides fragilis
KW - host-pathogen interaction
KW - metalloenzyme
KW - neutralization
KW - single-domain antibody
KW - structure and function
UR - https://www.scopus.com/pages/publications/105027706184
U2 - 10.1016/j.chembiol.2025.12.009
DO - 10.1016/j.chembiol.2025.12.009
M3 - 文章
C2 - 41544614
AN - SCOPUS:105027706184
SN - 2451-9456
VL - 33
SP - 102-116.e6
JO - Cell Chemical Biology
JF - Cell Chemical Biology
IS - 1
ER -